암 환자 71.5%가 생존하지만… 항암 신약 승인은 미국보다 3~4년 늦어

<div class="figure-img" data-ke-type="image" data-ke-style="alignCenter" data-ke-mobilestyle="widthOrigin" data-link="http://cafe.daum.net/subdued20club/ReHf" data-link-newwindow="_blank"><a href="http://cafe.daum.net/subdued20club/ReHf" target="_blank" class="ke-link"><img src="https://t1.daumcdn.net/cafeattach/1IHuH/db3bc991cc811264a000cb9ff8aa909ffe0048c9" data-img-src="https://t1.daumcdn.net/cafeattach/1IHuH/db3bc991cc811264a000cb9ff8aa909ffe0048c9" data-origin-width="474" data-origin-height="227"></a></div><p style="text-align: center;">출처 : <a href="https://n.news.naver.com/mnews/article/469/0000775491?sid=103" target="_blank" class="ke-link">https://n.news.naver.com/mnews/article/469/0000775491?sid=103</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="암 환자 71.5%가 생존하지만… 항암 신약 승인은 미국보다 3~4년 늦어" data-og-description="국내 암 환자가 수술 기법 등 치료 기술 발전으로 5년 생존율이 71.5%에 달하는 것으로 나타났다. 특히 위암·결장암·직장암 생존율은 경제협력개발기구(OECD) 회원국 가운데 1위를 기록했고 폐암" data-og-host="n.news.naver.com" data-og-source-url="https://n.news.naver.com/mnews/article/469/0000775491?sid=103" data-og-url="https://n.news.naver.com/mnews/article/469/0000775491?sid=103" data-og-image="https://scrap.kakaocdn.net/dn/TLXvZ/hyUL4s6gNX/A8eAK8CPuDyhCPqSnDuH1K/img.jpg?width=640&height=416&face=0_0_640_416,https://scrap.kakaocdn.net/dn/bs0dJG/hyULYfjVgk/7wY721HgUDrn6otY7HHwFk/img.jpg?width=640&height=416&face=0_0_640_416"><a href="https://n.news.naver.com/mnews/article/469/0000775491?sid=103" target="_blank" data-source-url="https://n.news.naver.com/mnews/article/469/0000775491?sid=103"><div class="og-image"><img src="https://scrap.kakaocdn.net/dn/TLXvZ/hyUL4s6gNX/A8eAK8CPuDyhCPqSnDuH1K/img.jpg?width=640&height=416&face=0_0_640_416,https://scrap.kakaocdn.net/dn/bs0dJG/hyULYfjVgk/7wY721HgUDrn6otY7HHwFk/img.jpg?width=640&height=416&face=0_0_640_416" alt="" xxonerror="this.src="//img1.kakaocdn.net/thumb/C200x200/?fname=https%3A%2F%2Ft1.daumcdn.net%2Fcafe_image%2Fcafe_meta_image_190529.png""></div><div class="og-text"><p class="og-title">암 환자 71.5%가 생존하지만… 항암 신약 승인은 미국보다 3~4년 늦어</p><p class="og-desc">국내 암 환자가 수술 기법 등 치료 기술 발전으로 5년 생존율이 71.5%에 달하는 것으로 나타났다. 특히 위암·결장암·직장암 생존율은 경제협력개발기구(OECD) 회원국 가운데 1위를 기록했고 폐암</p><p class="og-host">n.news.naver.com</p></div></a></div><div class="figure-img" data-ke-type="image" data-ke-style="alignCenter" data-ke-mobilestyle="widthOrigin"><img src="https://t1.daumcdn.net/cafeattach/1IHuH/7954ed35e675c4ae45e5a436109babc945fb8976" class="txc-image" data-img-src="https://t1.daumcdn.net/cafeattach/1IHuH/7954ed35e675c4ae45e5a436109babc945fb8976" data-origin-width="700" data-origin-height="810"></div><div class="figure-img" data-ke-type="image" data-ke-style="alignCenter" data-ke-mobilestyle="widthOrigin"><img src="https://t1.daumcdn.net/cafeattach/1IHuH/8b430e43f87e95bad0ee8c43d5fadc1be14cad80" class="txc-image" data-img-src="https://t1.daumcdn.net/cafeattach/1IHuH/8b430e43f87e95bad0ee8c43d5fadc1be14cad80" data-origin-width="690" data-origin-height="723"></div><p style="text-align: center;"> </p><p style="text-align: center;"> </p><p style="text-align: center;">여시들아 무섭다고 건강검진 스킵하지말고<br>찌찌 찌부 꼭 잘하고 다니란 말이야 (콱)</p><p style="text-align: center;"> </p><p style="text-align: center;"> </p>